JP2011518178A5 - - Google Patents

Download PDF

Info

Publication number
JP2011518178A5
JP2011518178A5 JP2011505210A JP2011505210A JP2011518178A5 JP 2011518178 A5 JP2011518178 A5 JP 2011518178A5 JP 2011505210 A JP2011505210 A JP 2011505210A JP 2011505210 A JP2011505210 A JP 2011505210A JP 2011518178 A5 JP2011518178 A5 JP 2011518178A5
Authority
JP
Japan
Prior art keywords
seq
composition
angiogenesis
optionally substituted
activation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2011505210A
Other languages
English (en)
Japanese (ja)
Other versions
JP2011518178A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2009/040848 external-priority patent/WO2009129408A2/en
Publication of JP2011518178A publication Critical patent/JP2011518178A/ja
Publication of JP2011518178A5 publication Critical patent/JP2011518178A5/ja
Pending legal-status Critical Current

Links

JP2011505210A 2008-04-16 2009-04-16 病的血管形成および脈管透過性の処置用の組成物および方法 Pending JP2011518178A (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US4558008P 2008-04-16 2008-04-16
US61/045,580 2008-04-16
US7388008P 2008-06-19 2008-06-19
US61/073,880 2008-06-19
PCT/US2009/040848 WO2009129408A2 (en) 2008-04-16 2009-04-16 Compositions and methods for treating pathologic angiogenesis and vascular permeability

Publications (2)

Publication Number Publication Date
JP2011518178A JP2011518178A (ja) 2011-06-23
JP2011518178A5 true JP2011518178A5 (enExample) 2012-07-26

Family

ID=41199735

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2011505210A Pending JP2011518178A (ja) 2008-04-16 2009-04-16 病的血管形成および脈管透過性の処置用の組成物および方法

Country Status (8)

Country Link
US (1) US20100222401A1 (enExample)
EP (1) EP2262524A4 (enExample)
JP (1) JP2011518178A (enExample)
KR (1) KR20100133881A (enExample)
CN (1) CN101687014A (enExample)
BR (1) BRPI0903901A2 (enExample)
CA (1) CA2693001A1 (enExample)
WO (1) WO2009129408A2 (enExample)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2010512327A (ja) 2006-12-11 2010-04-22 ユニヴァーシティー オブ ユタ リサーチ ファウンデーション 病的血管形成および脈管透過性の処置用の組成物および方法
US8620879B2 (en) * 2009-10-13 2013-12-31 Google Inc. Cloud based file storage service
US20110087603A1 (en) * 2009-10-13 2011-04-14 Google Inc. Cloud based media player and offline media access
CN102233134A (zh) * 2010-04-30 2011-11-09 中国科学院上海生命科学研究院 Slit-robo介导的淋巴管形成及其应用
US8399404B2 (en) 2010-06-15 2013-03-19 The Hospital For Sick Children Methods and uses for inhibiting platelet coagulation
US10561707B2 (en) * 2013-09-08 2020-02-18 Technion Research And Development Foundation Ltd. Semaphorin 3C variants, compositions comprising said variants and methods of use thereof in treating eye diseases
WO2015183989A1 (en) * 2014-05-27 2015-12-03 Navigen, Inc. Arf6 inhibitors and methods of synthesis and use thereof
MX2017011170A (es) * 2015-03-02 2018-04-24 Univ Illinois Peptidos para inhibir la angiogenesis.
CN105726534A (zh) * 2016-02-17 2016-07-06 上海交通大学医学院附属仁济医院 SecinH3在制备抑制胃酸分泌药物中的应用
WO2017173327A1 (en) * 2016-03-31 2017-10-05 The Schepens Eye Research Institute, Inc. Endomucin inhibitor as an anti-angiogenic agent
CN108929383B (zh) * 2017-05-26 2021-10-15 阿思科力(苏州)生物科技有限公司 重组Slit2D2(C386S)-HSA融合蛋白及其在预防和/或治疗肺部炎症中的应用
US11077422B2 (en) * 2017-06-16 2021-08-03 Aquablok, Ltd. Spalling composite particles and methods of using them
CN108364289B (zh) * 2018-03-02 2021-05-14 成都斯斐德科技有限公司 Ivoct图像易损斑块自动检测方法
CN108715862A (zh) * 2018-05-28 2018-10-30 上海海洋大学 ddx19基因缺失斑马鱼突变体的制备方法
WO2021077064A1 (en) * 2019-10-18 2021-04-22 EMULATE, Inc. Brain-chip modeling neurodegeneration and neuroinflammation in parkinson's disease
WO2021184059A1 (en) * 2020-03-14 2021-09-23 Newsouth Innovations Pty Limited Treatment methods

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5480975A (en) * 1994-02-08 1996-01-02 Brigham And Women's Hospital Induction of vascular endothelial growth factor (VEGF) by transition metals
US6372958B1 (en) * 1999-05-26 2002-04-16 The University Of Utah Research Foundation Transgenic mouse with endogenous endoglin gene disruption
US6960651B2 (en) * 1999-06-29 2005-11-01 Millennium Pharmaceuticals, Inc. TANGO 332 polypeptides
AU2001283062A1 (en) * 2000-08-02 2002-02-13 The Johns Hopkins University Endothelial cell expression patterns
US7939497B2 (en) * 2002-03-08 2011-05-10 Shanghai Institutes For Biological Sciences, Cas Detection and modulation of slit and roundabount (robo) mediated angiogenesis and uses thereof
EP1534318A4 (en) * 2002-06-27 2009-07-01 Univ Utah Res Found METHOD AND COMPOSITIONS FOR MANIPULATING GUIDED NAVIGATION OF ENDOTHONE TUBES IN THE ANGIOGENESIS
DE102004055998A1 (de) * 2004-11-19 2006-05-24 Rheinische Friedrich-Wilhelms-Universität Bonn Niedermolekulare Inhibitoren von Guaninnucleotid-Austauschfaktoren der Cytohesin-Familie
DE102006054205A1 (de) * 2006-11-15 2008-05-29 Rheinische Friedrich-Wilhelms Universität Verwendung von Cytohesin-Inhibitoren zur chemischen Induktion von Langlebigkeit
JP2010512327A (ja) * 2006-12-11 2010-04-22 ユニヴァーシティー オブ ユタ リサーチ ファウンデーション 病的血管形成および脈管透過性の処置用の組成物および方法
CN102083452A (zh) * 2008-12-12 2011-06-01 犹他大学研究基金会 用于促进血管屏障功能和治疗肺纤维化的组合物和方法

Similar Documents

Publication Publication Date Title
JP2011518178A5 (enExample)
JP2020033357A5 (enExample)
ES2389258T3 (es) Composiciones y métodos para inhibir TGF-s
JP2013510125A5 (enExample)
JP2019517464A5 (enExample)
JP2019521111A5 (enExample)
JP2014193925A5 (enExample)
JP2017528486A5 (enExample)
JP2021523887A (ja) XIIa因子インヒビター
CN114026072A (zh) 治疗特发性肺纤维化的方法
JP6579714B2 (ja) 化合物
JP2016531871A5 (enExample)
CA2602563A1 (en) Combinations comprising at least one direct thrombin inhibitor for the treatment of thrombosis
RU2018131775A (ru) 6-арил-4-морфолин-1-илпиридоны, пригодные для лечения рака или диабета
RU2016112542A (ru) Новые активаторы растворимой гуанилатциклазы и их применение
CN113825754A (zh) 包括甲基和三氟甲基的双取代磺酰胺类选择性bcl-2抑制剂
JP2018525371A5 (enExample)
CA3011800A1 (en) Methods for treating cancer
JP2018525425A5 (enExample)
JP2014506582A5 (enExample)
JP2021500332A5 (enExample)
CA3001789A1 (en) Amide-substituted aromatic compounds for use in anti-angiogenic treatment
RU2018101473A (ru) Депо-препарат, содержащий сложный эфир лимонной кислоты
CA2689299A1 (en) Synergistic combination of anthranilamide pyridinureas and benzamide derivatives
CA2634216A1 (en) Thrombin receptor antagonists as prophylaxis to complications from cardiopulmonary surgery